PTRH2 and ductal breast carcinoma in situ: In contrast to normal and DCIS breast tissues, invasive breast carcinomas, both nodal negative and nodal positive subgroups, showed reduced cytoplasmic Bit1 immunoreactivity (Figure 1A v–viii).